2,184
Views
14
CrossRef citations to date
0
Altmetric
Editorial

Nanotherapeutics for the treatment of inflammatory bowel disease

, &
Pages 495-497 | Received 13 Dec 2016, Accepted 17 Mar 2017, Published online: 24 Mar 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Chunhua Yang & Didier Merlin. (2020) Can naturally occurring nanoparticle-based targeted drug delivery effectively treat inflammatory bowel disease?. Expert Opinion on Drug Delivery 17:1, pages 1-4.
Read now

Articles from other publishers (13)

Luhui Wang, Zihao Wei, Ling Lv & Changhu Xue. (2024) An efficient co-delivery system based on multilayer structural nanoparticles for programmed sequential release of resveratrol and vitamin D3 to combat dextran sodium sulfate-induced colitis in mice. International Journal of Biological Macromolecules 254, pages 127962.
Crossref
Yaming Zhang, Lu Liu, Tianyi Wang, Cong Mao, Pengfei Shan, Chak Sing Lau, Zhongyu Li, Weisheng Guo & Weiping Wang. (2023) Reactive Oxygen Species‐Responsive Polymeric Prodrug Nanoparticles for Selective and Effective Treatment of Inflammatory Diseases. Advanced Healthcare Materials 12:29.
Crossref
Yu Xu, Bei-Wei Zhu, Rong Sun, Xiang Li, Di Wu & Jiang-Ning Hu. (2023) Colon-Targeting Angelica sinensis Polysaccharide Nanoparticles with Dual Responsiveness for Alleviation of Ulcerative Colitis . ACS Applied Materials & Interfaces 15:22, pages 26298-26315.
Crossref
Zhiying Zeng, Changying Li, Ye Liu, Hui Chen & Xuli Feng. (2023) Delivery of Transcriptional Factors for Activating Antioxidant Defenses against Inflammatory Bowel Disease. ACS Applied Bio Materials 6:3, pages 1306-1312.
Crossref
Eder Lilia Romero, Maria Julia Altube, Ana Paula Perez & Maria Jose Morilla. 2023. Biotechnology Applied to Inflammatory Diseases. Biotechnology Applied to Inflammatory Diseases 193 240 .
Menghang Zu, Ya Ma, Brandon Cannup, Dengchao Xie, Yunjin Jung, Jinming Zhang, Chunhua Yang, Fei Gao, Didier Merlin & Bo Xiao. (2021) Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases. Advanced Drug Delivery Reviews 176, pages 113887.
Crossref
Yuge Zhao, Yuting Yang, Jiaxin Zhang, Rong Wang, Biyun Cheng, Dipika Kalambhe, Yingshu Wang, Zeyun Gu, Dongying Chen, Bing Wang & Yongzhuo Huang. (2020) Lactoferrin-mediated macrophage targeting delivery and patchouli alcohol-based therapeutic strategy for inflammatory bowel diseases. Acta Pharmaceutica Sinica B 10:10, pages 1966-1976.
Crossref
Jiaxin Zhang, Yuge Zhao, Tianling Hou, Hairong Zeng, Dipika Kalambhe, Bing Wang, Xiaoyan Shen & Yongzhuo Huang. (2020) Macrophage-based nanotherapeutic strategies in ulcerative colitis. Journal of Controlled Release 320, pages 363-380.
Crossref
Xin Zhou, Yao Liu, Xianfeng Wang, Xiaomeng Li & Bo Xiao. (2020) Effect of particle size on the cellular uptake and anti-inflammatory activity of oral nanotherapeutics. Colloids and Surfaces B: Biointerfaces 187, pages 110880.
Crossref
Ya Ma, Xiaoling Tong, Yamei Huang, Xin Zhou, Chunhua Yang, Jiucun Chen, Fangyin Dai & Bo Xiao. (2019) Oral Administration of Hydrogel-Embedding Silk Sericin Alleviates Ulcerative Colitis through Wound Healing, Anti-Inflammation, and Anti-Oxidation. ACS Biomaterials Science & Engineering 5:11, pages 6231-6242.
Crossref
Jun-Sik Jung, Chunhua Yang, Emilie Viennois, Mingzhen Zhang & Didier Merlin. (2019) Isolation, Purification, and Characterization of Ginger-derived Nanoparticles (GDNPs) from Ginger, Rhizome of Zingiber officinale. BIO-PROTOCOL 9:19.
Crossref
Jiulong Zhao, Xiaojun Cai, Wei Gao, Linlin Zhang, Duowu Zou, Yuanyi Zheng, Zhaoshen Li & Hangrong Chen. (2018) Prussian Blue Nanozyme with Multienzyme Activity Reduces Colitis in Mice. ACS Applied Materials & Interfaces 10:31, pages 26108-26117.
Crossref
Yilin Guo, Shiyu Zong, Yiqiong Pu, Benliang Xu, Tong Zhang & Bing Wang. (2018) Advances in Pharmaceutical Strategies Enhancing the Efficiencies of Oral Colon-Targeted Delivery Systems in Inflammatory Bowel Disease. Molecules 23:7, pages 1622.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.